{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:14Z","timestamp":1791331574131,"version":"4.3.1"},"reference-count":45,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,9,10]]},"abstract":"<jats:p> Follicular lymphoma (FL) is the second most frequent type of non-Hodgkin's lymphoma in adults. The disease is characterized by an indolent course with frequent relapses. Ultimately, resistance to chemotherapy or transformation to a more aggressive phase of the disease in the form of diffuse large B-cell lymphoma develops, and patients die as a result of their disease. Median survival is 8 to 10 years. The range is very wide, however, with patients surviving for more than 15 years and 10% to 15% of the patients who run a rapidly fatal course and die within 3 years after diagnosis. The translocation t(14;18) is the basic molecular defect in FL and results in protection from apoptosis by aberrant overexpression of bcl-2 protein. Accumulation of genomic alterations and clonal selection account for subsequent progression and transformation. Recently, the role of the immunologic microenvironment of FL in determining clinical behavior and prognosis has been substantiated. Combined genetic and immunologic data may now support a model for the development of FL as a disease of functional B cells in which specific molecular alterations infer intrinsic growth properties of the tumor cells as well as dictate a specific functional cross talk with the immunologic regulatory network resulting in extrinsic growth support. These insights may lead to improvement of risk stratification, but most importantly will provide tools for developing new targets and strategies for treatment. <\/jats:p>","DOI":"10.1200\/jco.2005.26.856","type":"journal-article","created":{"date-parts":[[2005,9,9]],"date-time":"2005-09-09T04:07:52Z","timestamp":1126238872000},"page":"6358-6363","source":"Crossref","is-referenced-by-count":143,"title":["Molecular Pathogenesis of Follicular Lymphoma: A Cross Talk of Genetic and Immunologic Factors"],"prefix":"10.1200","volume":"23","author":[{"given":"Daphne","family":"de Jong","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"BIB1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6093263"},{"key":"BIB2","doi-asserted-by":"crossref","unstructured":"Bakshi A, Jensen JP, Goldman P et al: Cloning of the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18 Cell 41: 899,1985-906,","DOI":"10.1016\/S0092-8674(85)80070-2"},{"key":"BIB3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.21.7439"},{"key":"BIB4","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90174-8"},{"key":"BIB5","unstructured":"Limpens J, de Jong D, van Krieken JHJM, et al: Bcl-2\/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271,1991-2276,"},{"key":"BIB6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528"},{"key":"BIB7","unstructured":"Aster JC, Kobayashi Y, Shiota M, et al: Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 141:291,1992-299,"},{"key":"BIB8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.19.8910"},{"key":"BIB9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.3.223"},{"key":"BIB10","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/17.5.1013"},{"key":"BIB11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3604"},{"key":"BIB12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400849"},{"key":"BIB13","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700051"},{"key":"BIB14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2482"},{"key":"BIB15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.9.3081"},{"key":"BIB16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402707"},{"key":"BIB17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1998.tb01447.x"},{"key":"BIB18","doi-asserted-by":"publisher","DOI":"10.1002\/path.1689"},{"key":"BIB19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4265"},{"key":"BIB20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04086.x"},{"key":"BIB21","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.1103"},{"key":"BIB22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198701083160204"},{"key":"BIB23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1043.1043"},{"key":"BIB24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.12.006"},{"key":"BIB25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.4.1437.bloodjournal8841437"},{"key":"BIB26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2140.x"},{"key":"BIB27","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10314"},{"key":"BIB28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.282"},{"key":"BIB29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04502.x"},{"key":"BIB30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01264.x"},{"key":"BIB31","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1409"},{"key":"BIB32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0437875100"},{"key":"BIB33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041869"},{"key":"BIB34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2298"},{"key":"BIB35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048257"},{"key":"BIB36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.02075.x"},{"key":"BIB37","doi-asserted-by":"publisher","DOI":"10.1002\/path.1478"},{"key":"BIB38","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63640-1"},{"key":"BIB39","doi-asserted-by":"publisher","DOI":"10.1078\/0344-0338-00421"},{"key":"BIB40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00550.x"},{"key":"BIB41","unstructured":"Airoldi I, Guglielmino R, Ghiotto F, et al: Cytokine gene expression in neoplastic B cells from human mantle cell, follicular and marginal zone lymphomas and their postulated normal counterparts. Cancer Res 61:1285,2001-1290,"},{"key":"BIB42","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000053913.85892.E9"},{"key":"BIB43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2947"},{"key":"BIB44","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1589"},{"key":"BIB45","doi-asserted-by":"crossref","unstructured":"Vanasse GJ, Winn RK, Rodov S, et al: Bcl-2 overexpression leads to increases in suppressor of cytokine signalling-3 in B cells and de novo follicular lymphoma. Mol Can Res 2:620,2004-631,","DOI":"10.1158\/1541-7786.620.2.11"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.26.856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:12:46Z","timestamp":1653513166000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.26.856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,10]]},"references-count":45,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2005,9,10]]}},"alternative-id":["10.1200\/JCO.2005.26.856"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.26.856","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,10]]}}}